Quick answers
- What is Kazano?
- Kazano is a brand name of Alogliptin and metformin hydrochloride, a prescription medicine. The FDA NDC Directory lists 2 Kazano products in 2 strengths and forms.
- Who makes Kazano?
- Takeda Pharms USA holds the FDA application for Kazano (NDA203414, approved January 25, 2013).
- Is there a generic or store brand of Kazano?
- Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a Kazano product, 3 of them generic. Ask your pharmacist whether one is right for you.
- Has Kazano been recalled?
- No recall linked to Kazano products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Kazano is
Each Kazano product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Alogliptin and metformin hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| alogliptin benzoate 12.5 mg · metformin hydrochloride 1000 mg tablet, film coated (oral) | Kazano | 2 products, 2 companies | DailyMed |
| alogliptin benzoate 12.5 mg · metformin hydrochloride 500 mg tablet, film coated (oral) | Kazano | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Alogliptin and metformin hydrochloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA203414 | Takeda Pharms USA | January 25, 2013 | 2 |
Companies that list Kazano
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Kazano products.
- Takeda Pharmaceuticals America, Inc.2 products
Recalls
No recall linked to Kazano products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.